Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000362317 | SCV000345619 | uncertain significance | not provided | 2016-08-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001298709 | SCV001487773 | uncertain significance | Nephronophthisis | 2022-09-03 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 742 of the INVS protein (p.Val742Met). This variant is present in population databases (rs115598824, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with INVS-related conditions. ClinVar contains an entry for this variant (Variation ID: 290949). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002487289 | SCV002779784 | uncertain significance | Infantile nephronophthisis | 2024-03-08 | criteria provided, single submitter | clinical testing | |
3billion | RCV002487289 | SCV005328785 | likely benign | Infantile nephronophthisis | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |
Gene |
RCV000362317 | SCV005376795 | uncertain significance | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |